Answers are grounded in this paper and cite their sources.
This research presents a secondary evaluation of data from a previously conducted randomized, double-blind, placebo-controlled trial investigating the potential of fermented oyster extract (FGO) to enhance linear growth in children aged 6–11 years diagnosed with idiopathic or constitutional short stature. A total of 100 subjects with heights below the 25th percentile were randomly allocated to receive either 500 mg of FGO or a placebo daily over a 24-week period. The principal measure of efficacy was increase in stature, with secondary assessments including height velocity (HV), height standard deviation scores (SDS), bone age (BA), growth-related hormones (growth hormone, insulin-like growth factor 1 [IGF-1], and insulin-like growth factor-binding protein 3 [IGFBP-3]), bone metabolism indicators (deoxypyridinoline, osteocalcin), luteinizing hormone (LH), and safety metrics. The per-protocol analysis encompassed 93 participants (experimental group [EG], n = 46; control group [CG], n = 47). The EG demonstrated a statistically significant greater increase in height compared with the CG (4.10 ± 1.57 cm vs. 2.94 ± 0.73 cm; p < 0.001). Subgroup assessments indicated the most pronounced effects in children within the 3rd to 25th percentiles, where the height difference between groups reached 1.23 cm (p < 0.001). Both HV and SDS exhibited meaningful improvements in the EG across all percentiles analyzed. Although IGF-1 levels showed similar reductions in both groups, IGFBP-3 levels were more consistently maintained in the EG (p = 0.019), indicating the possibility of enhanced IGF-1 bioactivity. BA measurements and bone turnover markers remained within expected ranges, and no severe adverse reactions were reported. These outcomes suggest FGO could be a safe and effective nutritional strategy for stimulating height increase in children with mild forms of short stature. Future investigations should consider exploring potential sex-specific responses and detailed hormonal pathways underlying these effects.
No takes yet. Share an insight, caveat, or question.
Rheu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: